Haemonetics Corp (NYSE:HAE)
$ 83.51 -1.75 (-2.05%) Market Cap: 4.19 Bil Enterprise Value: 5.21 Bil PE Ratio: 34.65 PB Ratio: 4.79 GF Score: 76/100

Q3 2022 Haemonetics Corp Earnings Call Transcript

Feb 08, 2022 / 01:00PM GMT
Release Date Price: $54.56 (+16.16%)
Operator

Good day, and thank you for standing by. Welcome to the Haemonetics Corporation's Third Quarter Fiscal 2022 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Olga Guyette, Director, Investor Relations. Please go ahead.

Olga Guyette
Haemonetics Corporation - Director of IR

Thank you, and good morning, everyone. Thank you for joining us for Haemonetics' Third Quarter Fiscal '22 Conference Call and Webcast. I'm joined today by Chris Simon, our CEO; and Bill Burke, our CFO. This morning, we posted our third quarter fiscal '22 results to our Investor Relations website, along with our updated fiscal '22 guidance and the analytical tables with the information we'll refer to on this call.

Additionally, we provided a complete P&L, balance sheet, summary statement of cash flows as well as reconciliations of our GAAP to non-GAAP financial results and guidance. Before we get started, unless otherwise noted, all revenue growth rates discussed

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot